BioSpace News Archive

Drug Development

Last Patient Included in Alzecure’s Phase II Clinical Trial in Peripheral Neuropathic Pain with The Non-Opioid ACD440

AlzeCure Pharma AB announced that the last patient has now been included in the ongoing Phase II clinical study with ACD440, the lead non-opioid drug candidate in the Painless platform, which is being developed against peripheral neuropathic pain.

January 31, 2023
·
5 min read
Pharm Country

HUTCHMED to Announce 2022 Final Results

HUTCHMED Limited will be announcing its final results for the year ended December 31, 2022 on Tuesday, February 28, 2023 at 3:30 am Eastern Standard Time / 8:30 am Greenwich Mean Time / 4:30 pm Hong Kong Time.

January 31, 2023
·
1 min read
Business

Appendix 4C Quarterly Activity ReportMesoblast Operational and Financial Highlights for Quarter Ended December 31, 2022

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, provided an activity report for the second quarter ended December 31, 2022.

January 31, 2023
·
9 min read
Biotech Bay

Reviva Pharmaceuticals to Present at the 2023 BIO CEO and Investor Conference

Reviva Pharmaceuticals Holdings, Inc. today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the BIO CEO and Investor Conference being held February 6–9, 2023.

January 31, 2023
·
2 min read
Aplantex Raises $ 1.3 M in Initial Round of Financing

Mr. Patrick Charest, B. Sc., P. Eng., Aplantex’s CEO is pleased to announce that its initial round of financing was successfully completed.

January 31, 2023
·
1 min read
Genetown

Immuneering To Present at Guggenheim 2023 Oncology Conference

Immuneering Corporation today announced that management will present at Guggenheim’s 2023 Oncology Conference to discuss the company’s pipeline, platform, and business strategy.

January 31, 2023
·
2 min read
Business

Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27Axsome to host conference call and webcast on Monday, Feb. 27, 2023, at 8:00 a.m. ET

Axsome Therapeutics, Inc. today announced that it will report its financial results for the fourth quarter and full year of 2022 on Monday, Feb. 27, 2023, before the opening of the U.S. financial markets.

January 31, 2023
·
4 min read
Business

Hillstream BioPharma Signs an Exclusive Option Agreement to Advance Next-Generation Anti-MUC1-C Agents for Drug Resistant Cancers

Hillstream BioPharma, Inc. today announced signing an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein.

January 31, 2023
·
5 min read
BioMidwest

Surmodics to Host Virtual Annual Meeting of Shareholders - January 31, 2023

Surmodics, Inc. will hold its Annual Meeting of Shareholders on Thursday, February 9, at 4 p.m. CT (5 p.m. ET), as a virtual meeting.

January 31, 2023
·
1 min read
BioMidwest

Basking Biosciences to Present Clinical Trial Results on First Reversible Thrombolytic Agent at American Heart Association International Stroke Conference 2023

Basking Biosciences today announced the company will be presenting three oral presentations and two moderated posters concerning the company’s novel drug candidate at the American Heart Association’s 2023 International Stroke Conference (ISC).

January 31, 2023
·
3 min read